Opioid mediated effects on the immune system: Sympathetic nervous system involvement

Journal of Neuroimmunology

Volumn 83, Issue 1-2, 1998, Pages 29-35

  Hall, David M ^a   Suo, Jin Liang ^a   Weber, Richard J ^a  

^a Section of Medical Sciences   (United States)

Author keywords

Central nervous system; Immunosuppression; Opioids; Sympathetic nervous system

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 5 HYDROXYINDOLEACETIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BUPRENORPHINE; CATECHOLAMINE; CONCANAVALIN A; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; FENTANYL; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MORPHINE; NADOLOL; NORADRENALIN; OPIATE; PHYTOHEMAGGLUTININ; SEROTONIN; SUFENTANIL;

ADRENERGIC SYSTEM; ARTICLE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC TONE;

ANIMALS; HUMANS; MORPHINE; NARCOTICS; NEUROIMMUNOMODULATION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032520650     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00218-X     Document Type: Article

References (74)

1. Abrass C.K., O'Connor S.W., Scarpace P.J., Abrass I.B. Characterization of the β-adrenergic receptor of the rat peritoneal macrophages. J. Immunol. 135:1985;1338.
2. Band L.C., Pert A., Williams W., de Costa B.R., Rice K.C., Weber R.J. Central μ-opioid receptors mediate suppression of natural killer activity in vivo. Prog. Neuroendocrinol. Immunol. 5:1992;95-101.
3. Bartik M.M., Brooks W.H., Roszman T.L. Modulation of T cell proliferation by stimulation of the β-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell. Immunol. 148:1993;408.
4. Bayer B.M., Daussin S., Hernandez M., Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology. 29:1990;369-374.
5. Bayer B.M., Hernandez M., Irvin L. Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. Alcohol, Immunomodulation, AIDS. 325:1990;273-282.
6. Bayer B.M., Gastonguay M.R., Hernandez M.C. Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology. 23:1992;117-124.
7. Bayer B.M., Mulroney S.E., Hernandez M.C., Ding X.Z. Acute infusions of cocaine result in time- and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacology. 29:1995;19.
8. Beilin B., Martin F.C., Shavit Y., Gale R.P., Liebeskind J.C. Suppression of natural killer cell activity by high-dose narcotic anaesthesia in rats. Brain Behav. Immunol. 3:1989;129-137.
9. Brinkman, W.J., Hall, D.M., Suo, J.-L., Weber, R.J. (1997). Centrally mediated opioid-induced immunosuppression: Sympathetic nervous system involvement. In: Friedman, H., Madden, J., Klein, T. (Eds.), Drugs of Abuse, Immunomodulation and AIDS, Plenum, New York, NY, in press.
10. Brown S.M., Stimmel B., Taub R.N., Kochwa S., Rosenfield R.E. Immunologic dysfunction in heroin addicts. Arch. Internal Med. 134:1974;1001-1006.
11. Bryant et al., 1991.
12. Carlson S.L., Brooks W.H., Roszman T.L. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 24:1989;155.
13. Carr D.J.J., Carpenter G.W. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor. Neuroimmunomodulation. 2:1995;44.
14. Carr D.J.J., France C.P. Immune alterations in morphine-treated Rhesus monkeys. J. Pharmacol. Exp. Ther. 267:1993;9.
15. Carr D.J., Gebhardt B.M., Paul D. Alpha adrenergic and μ-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264:1993;1179-1186.
16. Carr, D.J.J, Mayo, S., Gebhardt, B., Porter, J. (1994a). Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J. Neuroimmunol., 53, 53.
17. Carr D.J.J., Baker M.L., Holmes C., Brockunier L.L., Bagley J.R., France C.P. Ohm3295-a fentanyl-related 4-heteroanilido piperidine with analgesic effects but not suppressive effects on splenic NK activity in mice. Int. J. Immunopharmacol. 16:1994;835-844.
18. Carr D.J.J., Rogers T.J., Weber R.J. The relevance of opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 213:1996;248.
19. Chao C.C., Sharp B.M., Pomeroy C., Filice G.A., Peterson P.K. Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther. 252:1990;605-609.
20. Chou R.C., Stinson M.W., Noble B.K., Spengler R.N. β-adrenergic receptor regulation of macrophage-derived tumor necrosis factor - α production from rats with experimental arthritis. J. Neuroimmunol. 67:1996;7.
21. Conway E.L., Brown M.J., Dollery C.T. Plasma catecholamine and cardiovascular responses to morphine and D-Ala-D-Leu-enkephalin in conscious rats. Arch. Int. Pharmacodyn. 265:1983;244.
22. Fecho K., Dykstra L.A., Lysle D.T. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265:1993;1079-1087.
23. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav. Immunity. 7:1993;253-270.
24. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277:1996;633-645.
25. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276:1996;626-636.
26. Feinstein D.L., Galea E., Reis D.J. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60:1993;1945.
27. Felsner P., Hofer D., Rinner I., Porta S., Korsatko W., Schauenstein K. Adrenergic suppression of peripheral blood T cell reactivity in the rat is due to activation of peripheral alpha 2-receptors. J. Neuroimmunol. 57:1995;27-34.
28. Felten S.Y., Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18:1987;37-48.
29. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135:1985;755s-765s.
30. Flores L.R., Hernandez M.C., Bayer B.M. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors. J. Pharmacol. Exp. Ther. 268:1994;1129.
31. Flores L.R., Dretchen K.L., Bayer B.M. Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur. J. Pharmacol. 318:1996;437.
32. Freier D.O., Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 270:1994;1127.
33. Gomez-Flores, R., Weber, R.J. (1998a). Immunomodulation of macrophages functions by opioids. In: Friedman, H., Madden, J., Klein, T. (Eds.), Drugs of Abuse, Immunomodulation and AIDS, Plenum, New York, NY (in press).
34. Gomez-Flores, R., Weber, R.J. (1998b). Opiatergic modulation of immune function II. In: Plotnikoff, N., Faith, R., Murgo, A., Good, R. (Eds), Stress, Immunity, and Cytokines, CRC Press, Boca Raton, FL, in press.
35. Heilig M., Irwin M., Grewal L., Sercarz E. Sympathetic regulation of T-helper cell function. Brain, Behav. Immunity. 7:1993;154-163.
36. Hernandez M.C., Flores L.R., Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267:1993;1336-1341.
37. Hussey H.H. Infections resulting from narcotic addiction report of 102 cases. Am. J. Med. 9:1950;186-193.
38. Irwin M., Hauger R.L., Jones L., Provencio M., Britton K.T. Sympathetic nervous system mediates central corticotrophin-releasing factor induced suppression of natural killer cytotoxicity. J. Pharmacol. Exp. Ther. 255:1990;101-107.
39. Jensen E.W., Bouchelouche P., Christensen N.J. Catecholamine responsiveness in human lymphocytes evaluated by intracellular calcium measurements. Scand. J. Clin. Lab. Invest. 55:1995;559.
40. Katafuchi T., Take S., Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J. Physiol. 465:1993;343.
41. Katz P., Zaytoun A.M., Fauci A.S. Mechanisms of human cell-mediated cytotoxicity: I. Modulation of natural killer cell activity by cyclic nucleotides. J. Immunol. 129:1982;287.
42. Khan M.M., Sansoni P., Silverman E.D., Engleman E.G., Melmon K.L. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem. Pharmacol. 35:1986;1137-1142.
43. Lewis J.W., Shavit Y., Terman G.W., Gale R.P., Liebeskind J.C. Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B). Nat. Immun. Cell Growth Regul. 3:1983;43-50.
44. Liebmann P.M., Hofer D., Felsner P., Wolfler A., Schauenstein K. Beta-blockade enhances adrenergic immunosuppression in rats via inhibition of melatonin release. J. Neuroimmunol. 67(2):1996;137-142.
45. Louria D.B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann. Internal Med. 67:1967;1-22.
46. Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., Dykstra L.A. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265:1993;1071-1078.
47. Lysle D.T., Hoffman K.E., Dykstra L.A. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J. Pharmacol. Exp. Ther. 277:1996;1533.
48. Mackenzie F.J., Leonard J.P., Cuzner M.L. Changes in lymphocyte beta-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 23:1989;93.
49. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:1995;417.
50. Makman M.H. Morphine receptors in immunocytes and neurons. Adv. Neuroimmunol. 4:1994;69.
51. Molitor et al., 1993.
52. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., Kreek M.J. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250:1989;606-610.
53. Provinciali M., Di Stefano G., Stronati S., Raffaeli W., Pari G., Fabris N. Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients. Int. J. Immunopharmacol. 18:1996;577.
54. Rojavin M., Szabo I., Bussiere J.L., Rogers T.J., Adler M.W., Eisenstein T.K. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci. 53:1993;997.
55. Sanders V.M., Munson A.E. Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 232:1985;395-400.
56. Sapira J.D. The narcotic addict as a medical patient. Am. J. Med. 45:1968;555-588.
57. Scott, M., Carr, D.J.J. (1996). Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner. J. Pharmacol. Exp. Ther. 278:980.
58. Serio M., Potenza M.A., Montagnani M., Mansi G., Mitolo-Chieppa D., Jirillo E. Beta-adrenoreceptor responsiveness of splenic macrophages in normotensive and hypertensive rats. Immunopharmacol. Immunotoxicol. 18:1996;247.
59. Shavit Y., Depaulis A., Martin F.C., Terman G.W., Pechnick R.N., Zane C.J., Gale R.P., Liebeskind J.C. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U.S.A. A 83:1986;7114-7117.
60. Starec M., Rouveix B., Sinet M., Chau F., Desforges B., Pocidalo J.J., Lechat P. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus. J. Pharmacol. Exp. Ther. 259:1991;745-750.
61. Suo, J-L., Weber, R.J. (1998a). Immunosuppression following PAG morphine injection is correlated with activation of the HPA axis and is not blocked by mifepristone. In: Friedman, H., Madden, J., Klein, T. (Eds.), Drugs of Abuse, Immunomodulation and AIDS. Plenum, New York, NY (in press).
62. Suo, J-L., Weber, R.J. (1998b). Microinjection of morphine in the periaqueductal gray matter induces immunosuppression through a glucocorticoid-independent mechanism. J. Immunol. (Submitted).
63. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145:1990;1430.
64. Spengler R.N., Chensue S.W., Giacherio D.A., Blenk N., Kunkel S.L. Endogenous norepinephrine regulates tumor necrosis factor - a production from macrophages in vitro. J. Immunol. 152:1994;3024.
65. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., Baud L. Regulation of interleukin-10 production by β-adrenergic agonists. Eur. J. Immunol. 26:1996;2601.
66. Tubaro E., Borelli G., Croce C., Cavallo G., Santiangeli C. Effect of morphine on resistance to infection. J. Infect. Dis. 148:1983;656-666.
67. Tubaro E., Santiangeli C., Belogi L., Borelli G., Cavallo G., Croce C., Avico U. Methadone vs. morphine: comparison of their effect on phagocytic functions, Int. J. Immunopharmacol. 9:1987;7.
68. Watson R.R., Nguyen T.H. Suppression by morphine and ethanol of tumor cell cytotoxic activity released by macrophages from retrovirally infected mice upon in vitro stimulation by beta carotene. Prog. Clin. Biol. Res. 325:1990;79-91.
69. Weber, R.J., Pert, C.B. (1984). Opiatergic Modulation of the Immune System. In: Muller, E.E., Genazzani, A.R. (Eds.), Central and Peripheral Endorphins: Basic and Clinical Aspects, Raven, New York, p. 35-42.
70. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
71. Weber and Pert, 1991.
72. Weber, R.J., Pert, A. (1998) Electrical stimulation of the midbrain periaqueductal gray matter suppresses natural killer activity. In preparation for Brain Research.
73. Yeager M.P., Colacchio T.A. Effect of morphine on growth of metastatic colon cancer in vivo. Arch. Surg. 126:1991;454-456.
74. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., Guyre P.M. Morphine inhibits spontaneous and cytokine enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:1995;500-508.